| William Harrison Moore Jr, MD | |
|
3368 Highway 280, Suite 111, Alexander City, AL 35010-3393 | |
| (256) 234-3477 | |
| (256) 234-9866 |
| Full Name | William Harrison Moore Jr |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 39 Years |
| Location | 3368 Highway 280, Alexander City, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700804242 | NPI | - | NPPES |
| 00002851MOO | Medicaid | AL | |
| 51119786 | Other | AL | BLUE CROSS/BLUE SHIEL |
| Facility Name | Location | Facility Type |
|---|---|---|
| Russell Medical Center | Alexander city, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Russell Hospital Corporation | 6406754431 | 52 |
News Archive
The ICON7 study results suggest that improved progression-free survival with bevacizumab therapy for high-risk ovarian cancer may come at the cost of health-related quality of life.
Despite receiving supplemental food benefits, some families cannot afford enough infant formula and resort to the dangerous practice of formula "stretching" - watering down formula - to feed their babies, according to a Cincinnati Children's Hospital Medical Center study conducted at urban pediatric clinics.
Chromatrap has demonstrated that its unique solid state patented technology allows for ChIP-seq assays to be routinely performed from as little as 500 ng of chromatin.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 5 days ago
| Entity Name | The Russell Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417252537 PECOS PAC ID: 6406754431 Enrollment ID: O20110307000502 |
News Archive
The ICON7 study results suggest that improved progression-free survival with bevacizumab therapy for high-risk ovarian cancer may come at the cost of health-related quality of life.
Despite receiving supplemental food benefits, some families cannot afford enough infant formula and resort to the dangerous practice of formula "stretching" - watering down formula - to feed their babies, according to a Cincinnati Children's Hospital Medical Center study conducted at urban pediatric clinics.
Chromatrap has demonstrated that its unique solid state patented technology allows for ChIP-seq assays to be routinely performed from as little as 500 ng of chromatin.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Harrison Moore Jr, MD 3368 Highway 280, Suite 111, Alexander City, AL 35010-3393 Ph: (256) 234-3477 | William Harrison Moore Jr, MD 3368 Highway 280, Suite 111, Alexander City, AL 35010-3393 Ph: (256) 234-3477 |
News Archive
The ICON7 study results suggest that improved progression-free survival with bevacizumab therapy for high-risk ovarian cancer may come at the cost of health-related quality of life.
Despite receiving supplemental food benefits, some families cannot afford enough infant formula and resort to the dangerous practice of formula "stretching" - watering down formula - to feed their babies, according to a Cincinnati Children's Hospital Medical Center study conducted at urban pediatric clinics.
Chromatrap has demonstrated that its unique solid state patented technology allows for ChIP-seq assays to be routinely performed from as little as 500 ng of chromatin.
Screening a class of recently-developed drug compounds - so-called "CDK inhibitors" capable of blocking CDK7/12/13 proteins - against hundreds of different human cancer cell lines, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found that CDK12 inhibitors pack a particularly lethal punch to Ewing sarcoma, a rare cancer typically affecting children and young adults.
› Verified 5 days ago
Rory Adam Clawser, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3368 Highway 280 Ste 111, Alexander City, AL 35010 Phone: 256-234-3477 | |
Dr. James Victor Hamilton Ii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 44 Aliant Pkwy, Alexander City, AL 35010 Phone: 256-234-4131 Fax: 256-234-9979 | |
Dr. Davis Lee Sullivan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 59 Alison Dr Ste 8, Alexander City, AL 35010 Phone: 256-234-3477 | |
Katharine R Cooper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3368 Highway 280, Suite 205, Alexander City, AL 35010 Phone: 256-234-2464 Fax: 256-234-2440 |